CMS must ensure transparency, clarity and predictability by providing detailed guidance on comparator drug selection and the evaluation of evidence, according to a group of D.C.-based health policy researchers.

Bumping up hard against the reality of depleted data sources, three of AI’s top players have been acting like they’ve had no choice but to consider cutting corners.

Two-fifths of leaders at academic medical centers, 41%, see reducing average length of patient stay as far and away the No. 1 “most untapped” strategy to turn around falling operating margins.

The rumors, it seems, were true. Once the deal is finalized, Shockwave Medical will operate as a business unit within Johnson & Johnson MedTech.

CVS points out that, in pharmacy schools specifically, applications have decreased by more than 60% in less than a decade.

A new study from researchers at Cedars-Sinai Medical Center should put minds at ease that the conservative management approach will not result in litigation when guidelines are followed.

Providers and payers disagree on a lot of things. But the camps are united in their appreciation of workers who have skills relevant to advancing GenAI in healthcare. 

This recall is due to reports of “increased resistance” when using the devices. There have been 194 customer complaints about the issue so far.